These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19635404)

  • 1. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.
    Qin X; Jackson R; Marshall R; Lee L; Cao W; Zhan S; Hu Y
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):96-101. PubMed ID: 19237999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaled rectangle diagrams can be used to visualize clinical and epidemiological data.
    Marshall RJ
    J Clin Epidemiol; 2005 Oct; 58(10):974-81. PubMed ID: 16168342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?
    Kerr AJ; Broad J; Wells S; Riddell T; Jackson R
    Heart; 2009 Feb; 95(2):125-9. PubMed ID: 18381374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
    Woodward M; Tunstall-Pedoe H; Rumley A; Lowe GD
    Br J Haematol; 2009 Aug; 146(4):442-6. PubMed ID: 19549268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk assessment: audit findings from a nurse clinic--a quality improvement initiative.
    Waldron S; Horsburgh M
    J Prim Health Care; 2009 Sep; 1(3):226-31. PubMed ID: 20690387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
    Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
    Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using impedance cardiography to detect subclinical cardiovascular disease in women with multiple risk factors: a pilot study.
    Demarzo AP
    Prev Cardiol; 2009; 12(2):102-8. PubMed ID: 19476584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 14. QRISK--a new CVD risk score.
    Savill P
    Practitioner; 2007 Aug; 251(1697):7. PubMed ID: 17882892
    [No Abstract]   [Full Text] [Related]  

  • 15. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of risk prediction models in cardiovascular disease research.
    Cui J
    Ann Epidemiol; 2009 Oct; 19(10):711-7. PubMed ID: 19628409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded].
    Smulders YM; Thijs A; Twisk JW
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1610-3. PubMed ID: 18998267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CVD risk. License to screen: a new mobile intervention program.
    Hamel L; Harris DE
    Nurse Pract; 2009 Jun; 34(6):42-7. PubMed ID: 19474631
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cardiovascular risk determinants do exist and are clinically useful.
    Smulders YM; Thijs A; Twisk JW
    Eur Heart J; 2008 Feb; 29(4):436-40. PubMed ID: 18276616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.